|1||NCT01723202||Active, not recruiting||Dabrafenib With or Without Trametinib in Treating Patients With Recurrent Thyroid Cancer||
||53||All||18 Years and older (Adult, Older Adult)||NCT01723202||OSU-12064
|November 7, 2012||December 31, 2018||December 31, 2019||November 7, 2012||April 11, 2018||
|2||NCT02152995||Recruiting||Trametinib in Increasing Tumoral Iodine Incorporation in Patients With Recurrent or Metastatic Thyroid Cancer||
||35||All||18 Years and older (Adult, Older Adult)||NCT02152995||NCI-2014-01106
|August 14, 2014||July 31, 2021||June 2, 2014||October 15, 2019||
† Study has passed its completion date and status has not been verified in more than two years.